Dozee, a healthtech startup that offers contactless remote patient monitoring (RPM) solutions, has raised $6 million from a clutch of new and existing investors.

The company said it plans to use the Series A2 funds to expand in the Indian market and deepen its research and development capabilities.

Prime Venture Partners, 3one4 Capital and YourNest VC were the existing investors who participated in the funding round, while State Bank of India, J&A Partners Family office, and Dinesh Mody Ventures were the new investors.

At present, the company’s contactless RPM and artificial intelligence-based early warning system (EWS) is being used in more than 380 hospitals covering more than 50 districts. Over the next two years, Dozee plans to tap over 2,000 hospitals in more than 100 districts.

“In addition, the funding will provide a springboard for the company’s global expansion. Earlier this year, Dozee partnered with British International Investment (BII), the UK’s development finance institution (DFI) and impact investor, to upgrade 6,000 hospital beds in about 140 public hospitals across India and in other regions to transform the public healthcare landscape,” the company said in a statement.

Dozee, founded in 2015 by IIT graduates Mudit Dandwate and Gaurav Parchani, had raised $10 million in January 2022 in a funding round led by Gokul Rajaram, a solo capitalist, operator and angel investor who has backed 300 companies.

In 2021, Dozee had raised Rs 44 crore ($5.4 million) in a Series A funding round led by existing investor Prime Venture Partners, with participation of YourNest Venture Capital and 3one4 Capital. In total, the company has raised $24 million, according to a company spokesperson.In March last year, Dozee had made key hires in its product, innovations and clinical research departments. Romit Shankar had joined as head of product, Amar Dani was appointed as head of data science, Devaiah Somayanda had joined as head of HR, Bhupinder Singh Pawa as head, QARA, and Pooja Kadambi as head – innovations and clinical research.

Stay on top of technology and startup news that matters. Subscribe to our daily newsletter for the latest and must-read tech news, delivered straight to your inbox.